Decentralized Clinical Trials

The Clinical Trial Supply series is a unique platform for clinical trial sponsors and solution providers. This event is aimed at enabling knowledge-sharing, benchmarking and network-building amongst biopharma industry peers.

The Clinical Trial Supply East Coast is the meeting place for the pharmaceutical and biotechnology community to discover how to excel in clinical supply strategy as well as form key connections for long-term success.

Expanding with a significant range of hot topics on trial diversity, reframing complex oncology trials, patient centricity and decentralized trials; this event introduces a brand new second stream focusing on patient recruitment and engagement. The event will include the top industry experts to share their latest struggles and successes.

Clinical Trial Supply Europe is the meeting place for the pharmaceutical and biotechnology community to discover how to excel in clinical supply strategy as well as form key connections for long-term success.

The program will, through a variety of interactive session formats, offer insight on promoting successful collaboration between the clinical trials community and once again offer attendees practical take-aways that they can apply to their own studies. It will bring together the definitive group of executives responsible for clinical operations in oncology and enhancing the partnership with vendors.

Bringing together clinical operations experts from oncology pharma and biotech sponsor companies on the East Coast alongside technology vendors, CROs and patient advocates, this will provide a perfect platform to uncover new technologies, processes and solutions to operational challenges when running an oncology trial.

The program will look at the latest challenges and innovations in oncology operations including fostering relationships with clinical sites, innovating data management processes and navigating new regulations impacting oncology trials in the US. Featuring a brand new track on Patient Recruitment and Engagement, the conference will be the platform for innovative case studies and break out discussions to connect and enhance your knowledge in the

The Scientific Program features a diverse range of scientific sessions organized into two concurrent themed tracks covering issues such as Novel In Vitro and In Silico Assays to Predict Human Safety, In Vivo and Ex vivo Case Studies For Safety, Debate on the “Value” of Primary Tissue and In Vivo Studies and are disease Models Relevant in Safety Pharmacology, Macro Molecules Science: Antibodies, Oligo, and Peptides, Translation Beyond FIH Exposure Response Models, Macro Molecules Science: Gene therapy, Cell Therapy, mRNA and PROTAC, Derisking and Risk Mitigation Strategies, Clinical Cardiology, and much more! This will ensure attendees can stay abreast of new content and developments in key areas of interest. 

Patients as Partners® specializes in the relationship between pharma clinical operations and patients and patient advocacy in how to drive greater clinical efficiencies and great value for all stakeholders.

Co-produced with industry, patients and public-sector voices, the Patients as Partners events are the only conferences that demonstrate how Pharma can involve patients throughout the entire clinical development life cycle to drive greater efficiencies in clinical research.  The conferences delve into patient engagement ideas, strategies, partnerships, and tools to advance patient participation and achieve better outcomes in trials.

With guidance direct from regulatory authorities and industry leaders, providing insights into policy and real-world case studies to help you achieve your compliance goal.